Omphalia lapidescens
Contents
Nomenclature
Other Names:
Historical Use of Omphalia lapidescens
Omphalia lapidescens in Traditional Chinese Medicine
Background
Chinese Name (pinyin): Leiwan
Chinese Name :
Common Name :Omphalia
Specific Name : Omphalia
Scientific Name:
Collection : The drug is collected in autumn, washed clean and dried in the sun.
Description : Subspheroid or irregular masses, 1 - 3cm in diameter, externally blackish brown or greyish brown with somewhat prominent and fine reticulate striations. Texture hard, uneasily broken, fracture uneven, white or pale greyish yellow, powdery or granular often with yellowish brown marble like striations. Odourless, taste slightly bitter with a sensation of granule and slightly viscose on chewing but without residue. If the fracture shows brown and horny, it can not be used medicinally.
Identification : 1.Powder: pale grey, hyphae sticked together forming irregular masses, varrying in size, colourless, a few yellowish brown or brownish red. Scattered hyphae short with branches, about 4µm in diameter. Prisms of calcium oxalate fine up to about 8µm in diameter, some gathered in groups. Abundant needle crystal observed after adding sulfuric acid.2.To a small quantity of blackish brown hyphae scraped from the outer part add 1 drop of sodium hydroxide TS, a cherry red colour is produced which turns to yellow on acidifying with hydrochloric acid.
Processing : Wash clean, dry in the sun and break to pieces. Do not boil or bake at a high temperature.
Action : To kill worms.
Indication : taeniasis, ancylostomiasis, ascariais; intestinal parasitosis with abdominal pain or with infantile malnutrition
Precautions :
Dosage : 15 to 21 g of powdered Omphalia to be taken with boiled water after meal, 2 or 3 times daily on 3 consecutive days.
Storage : Preserve in a cool and dry place.
Synonymns for Omphalia lapidescens
Patent Medicines and Medicines with Multiple Ingredients that include Omphalia lapidescens
Pharmaceutical Information
Chemical Constituents
Evidence or the Use of Omphalia lapidescens in the Treatment of Epilepesy
Basic Science
Animal Studies
Cohort, Case-Control and Non-Randomized Trials
Randomized Controlled Trials
Meta-Analysis
1st Five Results: pubmed search
Yueyang Zhang, Yue Jiang, Yina Jia, Xiaoyu Pan, Tianrun Zhao, Kaiyue Wang, He Yan, Zhiqing Ma
Separation of anti-TMV active components and modes of action of Omphalia lapidescens.
Pestic Biochem Physiol: 2024, 198;105728
[PubMed:38225082]
[WorldCat.org]
[DOI]
(I p)
Rui Tada, Naohito Ohno, Yoshiyuki Adachi
Refinement and complete solution NMR analysis of the structure of a 6-branched 1,3-β-D-glucan (OL-2) isolate from Omphalialapidescens.
Carbohydr Res: 2023, 529;108849
[PubMed:37216698]
[WorldCat.org]
[DOI]
(I p)
Wenjun Xu, Zhenjie Fu, Yuqin Xu, Man Hei Cheung, Yan Chen, Meiai Lin, Hang Wen, Hang Lv, Chun Liang, Jianshu Lou, Yitao Chen
##Title##
Acta Biochim Biophys Sin (Shanghai): 2022, 54(12);1897-1908
[PubMed:36789688]
[WorldCat.org]
[DOI]
(I p)
Yuqin Xu, Wenjun Xu, Zhongxia Lu, Man Hei Cheung, Meiai Lin, Chun Liang, Jianshu Lou, Yitao Chen
##Title##
Nutr Cancer: 2022, 74(5);1780-1791
[PubMed:34601984]
[WorldCat.org]
[DOI]
(I p)
Fei Liu, Jin-Feng Chen, Yue Wang, Li Guo, Qin-Mei Zhou, Cheng Peng, Liang Xiong
Cytotoxicity of lanostane-type triterpenoids and ergosteroids isolated from Omphalia lapidescens on MDA-MB-231 and HGC-27 cells.
Biomed Pharmacother: 2019, 118;109273
[PubMed:31374354]
[WorldCat.org]
[DOI]
(I p)
